Other tumor-specific promoters used to drive E1-mediated virotherapy against various cancers include mucin-1 promoter [47], osteocalcin promoter [48], AFP promoter [49], midkine promoter [50], and COX-2 promoter [51, 52]. The gene discussed is AFP; the disease is cancer.